Phoenix Biotech Acquisition Corp.
NASDAQ:PBAX
5.85 (USD) • At close February 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | |
|---|---|---|
| Revenue
| 0.255 | 0 |
| Cost of Revenue
| 0 | 0 |
| Gross Profit
| 0.255 | 0 |
| Gross Profit Ratio
| 1 | 0 |
| Reseach & Development Expenses
| 0 | 0 |
| General & Administrative Expenses
| 2.841 | 0 |
| Selling & Marketing Expenses
| 0 | 0.251 |
| SG&A
| 2.841 | 0.252 |
| Other Expenses
| 0.064 | -0.08 |
| Operating Expenses
| 2.905 | 0.332 |
| Operating Income
| -0.069 | -0.332 |
| Operating Income Ratio
| -0.269 | 0 |
| Total Other Income Expenses Net
| 2.837 | -0 |
| Income Before Tax
| -0.069 | -0.332 |
| Income Before Tax Ratio
| -0.269 | 0 |
| Income Tax Expense
| 0.599 | -0.017 |
| Net Income
| -0.668 | -0.316 |
| Net Income Ratio
| -2.62 | 0 |
| EPS
| -0.037 | -0.014 |
| EPS Diluted
| -0.037 | -0.014 |
| EBITDA
| -5.742 | -0.332 |
| EBITDA Ratio
| -22.534 | 0 |